Bristol Myers Squibb

BMYNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$127.159 B

$62.25 -0.59%

Close of 22 Sept 2026

Revenue

$48.2B

#87 by revenue

Earnings

$7.05B

#70 by earnings

Shares outstanding

2,042,714,656

Latest filing cover page

P/E ratio

18.0

Cap ÷ net income

Other share classes

Bristol Myers Squibb lists more than one class of stock. Company figures above cover all classes combined.

CELG-RI

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#9PfizerPFE$159.2B
#10Vertex PharmaceuticalsVRTX$130.5B
#11Bristol Myers SquibbBMY$127.2B
#12SanofiSNY$103.7B
#13GSKGSK$102.6B

What if Bristol Myers Squibb were worth as much as…

Open the what-if tool →

Gold $30.2T

$14,800.88

Per share 238× higher

Bitcoin $1.74T

$852.62

Per share 13.7× higher

Nvidia $5.52T

$2,700.21

Per share 43.4× higher

Or at a round number

$200.0B $500.0B $1.00T $2.00T

Where these numbers come from

Share counts and financials for Bristol Myers Squibb are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.